Muireann Bolger

Key details

Muireann Bolger is deputy editor of World Intellectual Property Review and Life Sciences Intellectual Property Review in London, where she covers trademarks, brands, as well as wider developments across the intellectual property sector.

She regularly attends and covers major IP conferences around the world, reporting on the latest legal, commercial and policy developments and interviewing leading figures from across the sector. She has also co-authored industry reports with leading IP organisations, including the International Trademark Association (INTA).

She is the editor of the website’s Community & Inclusion channel and the annual Influential Women in IP list, which celebrates the achievements and contributions of leading women across the IP sector.

Originally from Ireland, Muireann has nearly two decades of experience reporting on brand developments, strategy, and wider business issues.

In her current role, she writes and edits news and analysis for an international audience of IP professionals, while also championing inclusion within the profession.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 415

Articles by Muireann Bolger

Notable IP partner joins Lathrop GPM
Biotech
Recruit from DLA Piper brings two decades of patent and technical experience in life sciences, biotechnology, and healthcare industries.   28 March 2023
Edwards Lifesciences revives Fintiv challenge
Americas
Medtech company wins reversal of earlier ruling | Door opens to mount a challenge of controversial rule | USPTO director‘s updated guidelines influence court’s reasoning.   14 March 2023
Don’t distort enablement law, Amgen tells SCOTUS
Pharma
Sanofi and Regeneron accused of wanting to change patent system | The US Supreme Court will decide whether a controversial court decision should stand.   9 March 2023
Pharma
The University of Minnesota had raised three key issues on appeal | Sovereign immunity was at the heart of the years-long dispute.   7 March 2023
article
Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.   28 February 2023
article
The move marks the firm’s second western merger this year | Joining firm has a strong presence in Denver and Asia markets.   28 February 2023
article
The move is part of a strategic plan, with a focus on patents.   15 February 2023
Americas
Jury rules that a medical device infringes a pair of Colibri patents | Medtronic fails to prove patent was invalid.   9 February 2023
article
The patent attorneys will be based in London and Birmingham.   9 February 2023
Pharma
New addition joins from Fish & Richardson where he was a principal for five years.   7 February 2023

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.